Thanks for your question. We will answer you soon.
What is the goal of Rheumatoid Arthritis (RA) Therapy?
James O'Dell, MD
University of Nebraska Medical Center, Omaha, NE

Date Added: 06/26/13

It's very important to understand, as a patient with rheumatoid arthritis, that since you're here in our office early in the course of your disease, we have an over 50% chance with our medications of putting you in complete remission from your disease as long as you take the medications. Of the peop...
---------------------------------------------------------- ----------------------------------------------------------
James R. O'Dell, MD is Larson Professor of Internal Medicine, Vice-Chairman of Internal Medicine and Chief of the Section of Rheumatology at the University of Nebraska Medical Center (UNMC) in Omaha. He also has served as Director of the Internal Medicine Residency Training Program at UNMC for the last 27 years where he has directed the training of over 600 internal medicine residents. Dr. O'Dell received his undergraduate degree at the University of Nebraska-Lincoln in electrical engineering. He received his medical degree and completed a residency and chief residency in Internal Medicine at the University of Nebraska College of Medicine. Dr. O'Dell completed a clinical and research fellowship in Rheumatology at the University of Colorado Health Sciences Center in Denver in 1984 and is board certified in both Internal Medicine and Rheumatology. Dr. O'Dell founded and has directed the Rheumatoid Arthritis Investigational Network (RAIN) for the last 20 years. RAIN is a group of rheumatologists who conduct investigator-initiated trials to find better treatments for rheumatoid arthritis. This research network has pioneered the use of combinations of medications to treat rheumatoid arthritis, was one of the first groups to describe genetic factors that predict response to therapy, and has done extensive work with the use of minocycline in the treatment of rheumatoid arthritis. Dr. O'Dell has published extensively, mostly in the area of rheumatoid arthritis and authored “Drug Therapy: Rheumatoid Arthritis” for the New England Journal of Medicine as well as the 2010 RA:Update for the Annual of Rheumatic Disease. He has presented frequently at national and international meetings and has more than 100 published articles in top level rheumatology journals. He has received many awards for teaching excellence, was recently honored with the Nebraska ACP Laureate Award and as a distinguished Scientist at UNMC. He has served on numerous American College of Rheumatology (ACR) committees over the last 20 years including time on both the ACR and REF BOD as well as a two-year term as President of the Research and Education Foundation of the ACR, Chair of Cooperate Relations Committee and Chair of the Registry Committee and is currently President-Elect of the College. Additionally, he recently served Co-editor of Arthritis and Rheumatism.
Have Additional Questions About RA?
Get answers from our physicians
Thank you for your question, and for helping us make this RA Community more robust and helpful to patients like yourself. We'll be in touch soon.